
|Videos|November 9, 2021
Rate of Treatment-Related Mortality, Most Common Causes in the Treatment of Burkitt Lymphoma
Adam Olszewski, MD, associate professor of medicine in Alpert Medical School at Brown University, discusses the rate of treatment-related mortality and the most common causes in the treatment of Burkitt lymphoma.
Advertisement
Pharmacy Times interviewed Adam Olszewski, MD, associate professor of medicine in Alpert Medical School at Brown University, to discuss his SOHO 2021 conference presentation on prognostication and treatment of Burkitt lymphoma in the modern era.
During the interview, Olszewski discussed the rate of treatment-related mortality and the most common causes in the treatment of Burkitt lymphoma.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Retatrutide Delivers Bariatric-Level Weight Loss in Pivotal Phase 3 TRIUMPH-1 Trial
2
Can GLP-1 Receptor Agonists Improve Outcomes in Patients at Risk for Endometrial Cancer?
3
Early Oral Antiviral Use Associated With Lower Risk of Post–COVID-19 Condition, Study Finds
4
Oral GLP-1 Orforglipron Is Approved for Obesity
5




































































































































